Stock & Company Details
enGene Holdings Inc $ENGN
Price:
N/A
N/A
67M
$106M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.70
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ENGN technical indicators
Latest enGene Holdings Inc (ENGN) indicator readings as of 2026-10-29.
ENGN's 14-day RSI is 37.0, in neutral territory. At $1.53 it is trading 65.3% below its 200-day moving average of $4.41, and below its 50-day average of $1.80. Price sits near the lower Bollinger Band ($1.45 to $1.89). ADX reads 22.6, sitting between trending and range-bound.
Overview
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
Finance Bot
Ask your questions
Start by typing a question below.
